IBIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (Form 8-K)

Item 7.01. FD Regulation Disclosure.

On August 16, 2022, iBio, Inc. (the “Company”) issued a press release announcing that it had recently completed its first manufacturing run of its proprietary core antigen under cGMP conditions using its FastPharming® manufacturing system. A copy of the press release is provided as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Section 7.01 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K is not deemed to be “filed” for purposes of Section 18 of the Securities Act. of 1934, as amended, or otherwise subject to the responsibilities of this section or sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Section 7.01 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K is not to be incorporated by reference in any filing with the Security and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of the language of general incorporation into such filing.

The press release attached as Exhibit 99.1 to this current report on Form 8-K includes “safe harbor” language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating that certain statements that it contains are “prospective” rather than historical.

The Company undertakes no duty or obligation to update or revise the information contained in this current report on Form 8-K, although it may do so from time to time as its management deems appropriate. Such updating may be effected by filing other reports or documents with the Security and Exchange Commissionthrough press releases or other public disclosures.

Item 9.01. Financial statements and supporting documents.

(d)  Exhibits.

  Exhibit
   Number       Exhibit Description
    99.1          iBio, Inc. Press Release dated August 16, 2022
                Cover Page Interactive Data File (embedded within the Inline XBRL
    104         document)

© Edgar Online, source Previews

Comments are closed.